Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly E Dooley

Showing results (21-30 of 170) with videos related to

Pageof 17
Sort By:
Future Microbiology|July 31, 2015
Can the addition of verapamil to bedaquiline-containing regimens improve tuberculosis treatment outcomes? A novel approach to optimizing TB treatmentGeetha Srikrishna, Shashank Gupta, Kelly E Dooley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2023
Cerebrospinal Fluid and Tuberculous MeningitisCaryn M Upton, Lubbe Wiesner, Kelly E Dooley, et al.
Infection and Drug Resistance|May 12, 2026
Tuberculosis Prevention in Pregnant Women Living with HIV: A Review of the Current Management Strategies and GuidanceSpencer C Darveau, Sharan Yadav, Kelly E Dooley, et al.
Advanced Drug Delivery Reviews|February 2, 2016
Challenges in the clinical assessment of novel tuberculosis drugsKelly E Dooley, Patrick P J Phillips, Payam Nahid, et al.
AIDS Research and Treatment|July 26, 2012
TB and HIV Therapeutics: Pharmacology Research PrioritiesKelly E Dooley, Peter S Kim, Sharon D Williams, et al.
The Journal of Antimicrobial Chemotherapy|December 24, 2014
Rifampicin and rifapentine significantly reduce concentrations of bedaquiline, a new anti-TB drugElin M Svensson, Stephen Murray, Mats O Karlsson, et al.
Current HIV/AIDS Reports|October 29, 2022
Evidence for Implementation: Management of TB in HIV and PregnancyAmanda J Jones, Jyoti S Mathad, Kelly E Dooley, et al.
Plos Medicine|July 6, 2019
Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiologyKelly E Dooley, Debra Hanna, Vidya Mave, et al.
Expert Review of Clinical Pharmacology|August 23, 2023
Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infectionEmmanuella Chinonso Osuala, Anushka Naidoo, Kelly E Dooley, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2013
Induction of influx and efflux transporters and cytochrome P450 3A4 in primary human hepatocytes by rifampin, rifabutin, and rifapentineBeth Williamson, Kelly E Dooley, Yuan Zhang, et al.
Pageof 17

Showing results (21-30 of 170) with videos related to

Sort By:
Pageof 17
Future Microbiology|July 31, 2015
Can the addition of verapamil to bedaquiline-containing regimens improve tuberculosis treatment outcomes? A novel approach to optimizing TB treatmentGeetha Srikrishna, Shashank Gupta, Kelly E Dooley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2023
Cerebrospinal Fluid and Tuberculous MeningitisCaryn M Upton, Lubbe Wiesner, Kelly E Dooley, et al.
Infection and Drug Resistance|May 12, 2026
Tuberculosis Prevention in Pregnant Women Living with HIV: A Review of the Current Management Strategies and GuidanceSpencer C Darveau, Sharan Yadav, Kelly E Dooley, et al.
Advanced Drug Delivery Reviews|February 2, 2016
Challenges in the clinical assessment of novel tuberculosis drugsKelly E Dooley, Patrick P J Phillips, Payam Nahid, et al.
AIDS Research and Treatment|July 26, 2012
TB and HIV Therapeutics: Pharmacology Research PrioritiesKelly E Dooley, Peter S Kim, Sharon D Williams, et al.
The Journal of Antimicrobial Chemotherapy|December 24, 2014
Rifampicin and rifapentine significantly reduce concentrations of bedaquiline, a new anti-TB drugElin M Svensson, Stephen Murray, Mats O Karlsson, et al.
Current HIV/AIDS Reports|October 29, 2022
Evidence for Implementation: Management of TB in HIV and PregnancyAmanda J Jones, Jyoti S Mathad, Kelly E Dooley, et al.
Plos Medicine|July 6, 2019
Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiologyKelly E Dooley, Debra Hanna, Vidya Mave, et al.
Expert Review of Clinical Pharmacology|August 23, 2023
Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infectionEmmanuella Chinonso Osuala, Anushka Naidoo, Kelly E Dooley, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2013
Induction of influx and efflux transporters and cytochrome P450 3A4 in primary human hepatocytes by rifampin, rifabutin, and rifapentineBeth Williamson, Kelly E Dooley, Yuan Zhang, et al.
Pageof 17